Physiologically based pharmacokinetic (PBPK) models used in radiopharmaceutical therapy (RPT) and theranostic digital twins are rapidly increasing in size and mechanistic detail, often containing tens to hundreds of parameters. While such models fit imaging a...
Institution profile
Co-founder at Ascinta
Rank #292 · 3 unique linked submissions.
People
Top contributors
Arman Rahmim
Radiopharmaceuticals, Theranostics, and Nuclear Medicine
Radiomics enables quantitative characterization of tumors from PET and CT imaging. When anatomic-region-specific cancer data are limited, transfer and semi-supervised learning can improve prediction by leveraging data from different regions; however, the basi...
Arman Rahmim
Radiopharmaceuticals, Theranostics, and Nuclear Medicine
To develop and evaluate a radiomic phenotyping and multi-lesion aggregation scheme to derive patient-level biomarkers for identifying progressive disease and predicting time-to-progression (TTP) in diffuse large B-cell lymphoma (DLBCL).
Arman Rahmim
Radiopharmaceuticals, Theranostics, and Nuclear Medicine